Nearly a decade of
Drugs to Watch

Review the history of
drugs identified as potential
blockbusters

Download Drugs to Watch 2022

Annually since January 2013, the Clarivate expert team has analyzed and selected the Drugs to Watch. While the underlying process has remained the same, the technologies have evolved, and new tools, such as Drug Timelines & Success Rates, are now available to inform the analysis.

Learn more about our methods

Key therapeutic development areas to watch

The drug innovation landscape is evolving, and many companies are developing platforms to address challenges in delivery and targeting across therapeutic areas.

Find out more about:

  • Cell and gene therapies
  • CRISPR
  • AI and machine learning discovery
  • RNA
  • Targeted cancer therapies

Download the report

Resources


Truly differentiate your drug

Access our global intelligence, advanced analytics and global team of experts.

Speak to our team